1Keating MJ,Lerner S,Kantarjian H,et al.The serum b2 microglobulin(b2M)level is more powerful than stage in predicting response and survival in chronic lymphocytic leukemia(CLL)[J].Blood,1995,86(1):606.
2Fayad L,Keating MJ,Reuben JM,et al.Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia:correlation with phenotypic characteristics and outcome[J].Blood,2001,97(1):256-263.
3Hailek M,WandersL,Ostwald M,et al.Serum b2 microglobulin and serum thymidine kinase are independent predictors of pro8ression-free survival in chronic lymphocytic leukemia and iramunocytoma[J].Leuk Lymphoma,1996,22(5-6):439-447.
4Hallek M,Langnnmayer I,Ned C,et al.Elevated serum thymidine kinase levels identify n subgroup at high risk of disease prosression in early non-smoldering chronic lymphocytic leukemia[J].Blood,1999,93(5):1732-1737.
5Di Baimondo F,Giustolisi R,Lerner S,et al.Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine[J].Ann Oncol,2001,12(5):621-625.
6Magnac C,Porcher R,Davi F,et al.Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL[J].Leukemia.2003,17(1),133-137.
7Serfati M,Chevret S,Ch88tang C,et al.Prognostic importance of serum soluble CD23 level in chronic lymphocytie leukemia[J].Blood,1996,88(11):4259-4264.
8Rambotti P,Davis S.Lactate dehydrogenase in normal and leukemic lymphocyte subpopulatiorm:evidence for the presence of abnormal T cells and B cells in chronic lymphocytic leukemia[J].Blood,1981,57(2):324-327.
